BACKGROUND: Tuberculosis incidence in resource poor countries remains high. We hypothesized that immune modulating co-infections such as helminths, malaria, and HIV increase susceptibility to latent tuberculosis infection (LTBI), thereby contributing to maintaining the tuberculosis epidemic. METHODS: Adults with sputum-positive tuberculosis (index cases) and their eligible household contacts (HHCs) were recruited to a cohort study between May 2011 and January 2012. HHCs were investigated for helminths, malaria, and HIV at enrolment. HHCs were tested using the QuantiFERON-TB Gold In-Tube (QFN) assay at enrolment and six months later. Overnight whole blood culture supernatants from baseline QFN assays were analyzed for cytokine responses usin...
Some vaccines show poor efficacy in tropical countries. Within a birth cohort in Uganda, we investig...
Background: Recent evidence highlights human cytomegalovirus (HCMV) and immune activation...
AbstractBackgroundBCG is used widely as the sole licensed vaccine against tuberculosis, but it has v...
Tuberculosis incidence in resource poor countries remains high. We hypothesized that immune modulati...
Background: M.tuberculosis (M.tb) is associated with enhanced T helper cell type 1 (Th1) immune resp...
BACKGROUND: Recent evidence highlights human cytomegalovirus (HCMV) and immune activation as risk fa...
BACKGROUND Helminth infections can negatively affect the immunologic host control, which may incr...
BACKGROUND: BCG is used widely as the sole licensed vaccine against tuberculosis, but it has variabl...
Tuberculosis (TB) causes significant morbidity and mortality on a global scale. The African region h...
Background: Recent evidence implicates human cytomegalovirus (HCMV), immune activation and inflammat...
Helminth infections can negatively affect the immunologic host control, which may increase the risk ...
Rates of tuberculosis (TB) in Africa are highest among people infected with HIV. Searching for addit...
OBJECTIVES: A growing evidence base implicates human cytomegalovirus (HCMV) as a risk factor for TB ...
BACKGROUND: Offspring of women with schistosomiasis may exhibit immune responsiveness to schistosome...
INTRODUCTION: Household contacts of patients with active pulmonary tuberculosis (TB) often have late...
Some vaccines show poor efficacy in tropical countries. Within a birth cohort in Uganda, we investig...
Background: Recent evidence highlights human cytomegalovirus (HCMV) and immune activation...
AbstractBackgroundBCG is used widely as the sole licensed vaccine against tuberculosis, but it has v...
Tuberculosis incidence in resource poor countries remains high. We hypothesized that immune modulati...
Background: M.tuberculosis (M.tb) is associated with enhanced T helper cell type 1 (Th1) immune resp...
BACKGROUND: Recent evidence highlights human cytomegalovirus (HCMV) and immune activation as risk fa...
BACKGROUND Helminth infections can negatively affect the immunologic host control, which may incr...
BACKGROUND: BCG is used widely as the sole licensed vaccine against tuberculosis, but it has variabl...
Tuberculosis (TB) causes significant morbidity and mortality on a global scale. The African region h...
Background: Recent evidence implicates human cytomegalovirus (HCMV), immune activation and inflammat...
Helminth infections can negatively affect the immunologic host control, which may increase the risk ...
Rates of tuberculosis (TB) in Africa are highest among people infected with HIV. Searching for addit...
OBJECTIVES: A growing evidence base implicates human cytomegalovirus (HCMV) as a risk factor for TB ...
BACKGROUND: Offspring of women with schistosomiasis may exhibit immune responsiveness to schistosome...
INTRODUCTION: Household contacts of patients with active pulmonary tuberculosis (TB) often have late...
Some vaccines show poor efficacy in tropical countries. Within a birth cohort in Uganda, we investig...
Background: Recent evidence highlights human cytomegalovirus (HCMV) and immune activation...
AbstractBackgroundBCG is used widely as the sole licensed vaccine against tuberculosis, but it has v...